The"spleen"in traditional Chinese medicine is the"acquired foundation"and the"source of qi and blood biochemistry".Strengthening the"spleen"is one of the important treat‐ment m...The"spleen"in traditional Chinese medicine is the"acquired foundation"and the"source of qi and blood biochemistry".Strengthening the"spleen"is one of the important treat‐ment methods in traditional Chinese medicine;The gut microbiota has been a hot topic in modern scientific research in recent years,and its nutritional and immune functions correspond to some of the functions of the spleen in traditional Chinese medicine.In terms of philosophy,traditional Chinese medicine emphasizes the balance between the spleen and the gut microbiota,emphasizing the importance of supporting the right and eliminating evil,preventing diseases before they occur,seeking the root cause of treat‐ment,and adapting measures to the three causes;Clinically,the treatment of obesity,con‐stipation,diarrhea and other diseases by invigorating the spleen and the treatment mechanism of acupuncture and moxibustion,chiropractic and invigorating the spleen are all related to microecology.This article combines relevant literature on traditional Chinese medicine's"spleen"and"spleen health"to explore the treatment concept,clinical application,and correlation with intestinal microbiota of traditional Chinese medicine's"spleen health".It also elaborates on the latest literature,aiming to exchange ideas with peers and promote research on the microbiota of traditional Chinese medicine's"spleen".展开更多
Non-alcoholic fatty liver disease and type 2 diabetes are common comorbidities or target organ damage,which can lead to adverse metabolism and increased risk of cardiovascular and cerebrovascular diseases.In the manag...Non-alcoholic fatty liver disease and type 2 diabetes are common comorbidities or target organ damage,which can lead to adverse metabolism and increased risk of cardiovascular and cerebrovascular diseases.In the management plan of non-alcoholic fatty liver disease and type 2 diabetes,there is no drug with significant efficacy or both.The dialectical idea of traditional Chinese medicine has a good curative effect and significant advantages in treating metabolic disorders.The author now reviewed a case of non-alcoholic steatohepatitis combined with type 2 diabetes.In this case,the method of invigorating the spleen and eliminating turbidity was effective,which effectively prevented the progression of liver disease in the patient,and T2DM was alleviated by maintaining within the standard range after the use of insulin was stopped.It can be said that“killing two birds with one stone”,more fully reflects the advantages of traditional Chinese medicine in the integrated treatment of metabolic-related diseases.展开更多
目的探讨补肾健脾药方联合FOLFOX化疗方案治疗脾肾阳虚型大肠癌患者的临床疗效。方法选取2019年8月—2021年8月期间昆明市中医医院收治的辨证为脾肾阳虚型的中晚期大肠癌患者92例,按随机数字表法分为对照组和治疗组,每组各46例。对照组...目的探讨补肾健脾药方联合FOLFOX化疗方案治疗脾肾阳虚型大肠癌患者的临床疗效。方法选取2019年8月—2021年8月期间昆明市中医医院收治的辨证为脾肾阳虚型的中晚期大肠癌患者92例,按随机数字表法分为对照组和治疗组,每组各46例。对照组接受单纯FOLFOX化疗方案治疗,治疗组患者接受FOLFOX化疗方案+健脾补肾法治疗,21 d为1个化疗周期。治疗3个周期后,观察比较两组患者临床疗效[疾病控制率(Disease control rate,DCR)]、化疗毒副作用发生及分级情况,治疗前后的中医症状积分、生活质量[生活质量问卷(Quality of life,QOL)、KPS评分量表(Karnofsky,KPS)]以及肿瘤标志物[血清癌胚抗原(Carcinoembryonic antigen,CEA)以及血清糖类抗原199(Carbohydrate antigen199,CA199)]水平。结果治疗后治疗组DCR为93.33%(42/45)明显高于对照组75.00%(33/44),差异有统计学意义(P<0.05)。治疗后两组患者中医症状积分较治疗前降低,差异有统计学意义(P<0.05);且治疗组中医症状积分较对照组明显降低,差异有统计学意义(P<0.05)。治疗后两组患者QOL、KPS评分均较治疗前升高,差异有统计学意义(P<0.05);且治疗组QOL、KPS评分均较对照组明显升高,差异有统计学意义(P<0.05)。治疗后两组患者血清CEA、CA199水平均较治疗前降低,差异有统计学意义(P<0.05);且治疗组血清CEA、CA199水平均较对照组明显降低,差异有统计学意义(P<0.05)。治疗期间,两组患者均未出现Ⅳ级程度的毒副作用。两组患者分级进行比较结果显示,对照组在恶心呕吐、腹泻这两项的反应剧烈程度高于治疗组,差异有统计学意义(P<0.05);两组患者在白细胞减少、血小板降低、转氨酶升高以及肌酐升高方面比较,差异无统计学意义(P>0.05)。结论FOLFOX化疗方案联合健脾补肾法治疗在改善中晚期大肠癌患者症状表现、生活质量,降低血清肿瘤标志物水平等方面更具优势,疗效佳,且能够降低化疗导致的胃肠道反应的剧烈程度,是治疗中晚期大肠癌的有效方案。展开更多
文摘The"spleen"in traditional Chinese medicine is the"acquired foundation"and the"source of qi and blood biochemistry".Strengthening the"spleen"is one of the important treat‐ment methods in traditional Chinese medicine;The gut microbiota has been a hot topic in modern scientific research in recent years,and its nutritional and immune functions correspond to some of the functions of the spleen in traditional Chinese medicine.In terms of philosophy,traditional Chinese medicine emphasizes the balance between the spleen and the gut microbiota,emphasizing the importance of supporting the right and eliminating evil,preventing diseases before they occur,seeking the root cause of treat‐ment,and adapting measures to the three causes;Clinically,the treatment of obesity,con‐stipation,diarrhea and other diseases by invigorating the spleen and the treatment mechanism of acupuncture and moxibustion,chiropractic and invigorating the spleen are all related to microecology.This article combines relevant literature on traditional Chinese medicine's"spleen"and"spleen health"to explore the treatment concept,clinical application,and correlation with intestinal microbiota of traditional Chinese medicine's"spleen health".It also elaborates on the latest literature,aiming to exchange ideas with peers and promote research on the microbiota of traditional Chinese medicine's"spleen".
基金The fifth batch of national training programs for clinical talents of traditional Chinese medicine(No.1[2022]of Chinese Medicine People’s Education Letter)Shaanxi Natural Science Basic Research Plan(2022JM-454)+1 种基金Scientific research project of Shaanxi Provincial Administration of Traditional Chinese Medicine(2021-PY-001)Science and Technology Project of Ankang Science and Technology Bureau(AK2020-SF-06,AK2021-SFZC-06).
文摘Non-alcoholic fatty liver disease and type 2 diabetes are common comorbidities or target organ damage,which can lead to adverse metabolism and increased risk of cardiovascular and cerebrovascular diseases.In the management plan of non-alcoholic fatty liver disease and type 2 diabetes,there is no drug with significant efficacy or both.The dialectical idea of traditional Chinese medicine has a good curative effect and significant advantages in treating metabolic disorders.The author now reviewed a case of non-alcoholic steatohepatitis combined with type 2 diabetes.In this case,the method of invigorating the spleen and eliminating turbidity was effective,which effectively prevented the progression of liver disease in the patient,and T2DM was alleviated by maintaining within the standard range after the use of insulin was stopped.It can be said that“killing two birds with one stone”,more fully reflects the advantages of traditional Chinese medicine in the integrated treatment of metabolic-related diseases.
文摘目的探讨补肾健脾药方联合FOLFOX化疗方案治疗脾肾阳虚型大肠癌患者的临床疗效。方法选取2019年8月—2021年8月期间昆明市中医医院收治的辨证为脾肾阳虚型的中晚期大肠癌患者92例,按随机数字表法分为对照组和治疗组,每组各46例。对照组接受单纯FOLFOX化疗方案治疗,治疗组患者接受FOLFOX化疗方案+健脾补肾法治疗,21 d为1个化疗周期。治疗3个周期后,观察比较两组患者临床疗效[疾病控制率(Disease control rate,DCR)]、化疗毒副作用发生及分级情况,治疗前后的中医症状积分、生活质量[生活质量问卷(Quality of life,QOL)、KPS评分量表(Karnofsky,KPS)]以及肿瘤标志物[血清癌胚抗原(Carcinoembryonic antigen,CEA)以及血清糖类抗原199(Carbohydrate antigen199,CA199)]水平。结果治疗后治疗组DCR为93.33%(42/45)明显高于对照组75.00%(33/44),差异有统计学意义(P<0.05)。治疗后两组患者中医症状积分较治疗前降低,差异有统计学意义(P<0.05);且治疗组中医症状积分较对照组明显降低,差异有统计学意义(P<0.05)。治疗后两组患者QOL、KPS评分均较治疗前升高,差异有统计学意义(P<0.05);且治疗组QOL、KPS评分均较对照组明显升高,差异有统计学意义(P<0.05)。治疗后两组患者血清CEA、CA199水平均较治疗前降低,差异有统计学意义(P<0.05);且治疗组血清CEA、CA199水平均较对照组明显降低,差异有统计学意义(P<0.05)。治疗期间,两组患者均未出现Ⅳ级程度的毒副作用。两组患者分级进行比较结果显示,对照组在恶心呕吐、腹泻这两项的反应剧烈程度高于治疗组,差异有统计学意义(P<0.05);两组患者在白细胞减少、血小板降低、转氨酶升高以及肌酐升高方面比较,差异无统计学意义(P>0.05)。结论FOLFOX化疗方案联合健脾补肾法治疗在改善中晚期大肠癌患者症状表现、生活质量,降低血清肿瘤标志物水平等方面更具优势,疗效佳,且能够降低化疗导致的胃肠道反应的剧烈程度,是治疗中晚期大肠癌的有效方案。